Navigation path

Pharmaceuticals - Community Register


Community list of not active orphan medicinal products


Product information

Recombinant human factor XIII (composed of two A subunits)

EU orphan designation number: EU/3/03/179
Active ingredient: Recombinant human factor XIII (composed of two A subunits)
Indication: Treatment of hereditary factor XIII deficiency
Sponsor: Novo Nordisk A/S
Novo Allé, DK-2880 Bagsvaerd, Danmark

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
15/12/2003 Orphan designation EMEA/OD/052/03 (2003)5037 of 12/12/2003
19/01/2005 Transfer of orphan designation EMEA/OD/052/03/T/01 (2004)5468 of 30/12/2004
23/07/2012 Removal of orphan designation from Community Register